Precision Medicine Market to Reach US$ 105.6 Billion by 2026, Globally |CAGR: 9.9%| UnivDatos Market Insights

NOIDA, India, Dec. 1, 2020 /PRNewswire/ — A comprehensive overview of the precision medicine market is recently added by UnivDatos Market Insights to its humongous database. The precision medicine market report has been aggregated by collecting informative data of various dynamics such as market drivers, restraints, and opportunities. Furthermore, the precision medicine market report offers a detailed analysis of the latest industry developments and trending factors in the market that are influencing the market growth. Furthermore, this statistical market research repository examines and estimates the precision medicine market at the global and regional levels. Global Precision Medicine Market is expected to grow at a CAGR of 9.9% from 2021-2026 to reach US$ 105.6 billion by 2026.

Market Overview

Precision medicine is known to be one of the most promising approaches for tackling the diseases that have thus far eluded effective treatments or cures. Several indications such as cancer, neurodegenerative diseases, and rare genetic conditions take an immense toll on individuals, families, and societies. Cancer is amongst the leading cause of mortality worldwide with an estimation of 9.6 million deaths in 2018. The most common cancers include lung (2.09 million cases), breast (2.09 million cases), colorectal (1.80 million cases), prostate (1.28 million cases), non-melanoma skin (1.04 million cases), stomach (1.03 million cases).

The rising demand for preventive care and advances in next-generation sequencing (NGS) technologies have resulted in an unprecedented proliferation and deluge of genomic sequence data, thereby driving the market growth of the precision medicine sector. In the last 15 years, the cost of mapping a human genome has fallen from US$ 100 million to below US$ 1,000, allowing the use of data from patient DNA to become a significant viable method to provide precise, actionable recommendations before symptoms occur. The growth of the industry is also fueled by scientific discovery, alignment of incentives, regulatory decisions, consumer interest and demand, and advances in technology. The growth of the market for precision medicine is also supported by the increasing patient adherence to treatment and rising prevalence of oncology indications.

Request Sample Copy of this Report @ https://univdatos.com/report/precision-medicine-market-current-analysis-and-forecast-2020-2026

Impact of COVID-19:

As the pandemic is spreading rapidly, clinicians treating COVID-19 are in desperate need of effective therapy, as the development of an effective vaccine remains a remote possibility. Given the urgent nature of the pandemic and the number of companies and researchers developing COVID-19 related therapies, there are more than 560 drug development programs in the pipeline with over 370 trials been reviewed by FDA. For instance, Boehringer Ingelheim initiated a Phase II study of BI 764198, a TRPC6 inhibitor to alleviate the damage to the lung and decrease the risk or severity of acute respiratory complications in patients hospitalized for COVID-19.

Ask for Price & Discounts @ https://univdatos.com/report/precision-medicine-market-current-analysis-and-forecast-2020-2026

Global Precision Medicine Market report is studied thoroughly with several aspects that would help stakeholders in making their decisions more curated.

By Technology, the market is primarily bifurcated into

  • Big Data Analytics
  • Bioinformatics
  • Gene Sequencing
  • Drug Discovery
  • Companion
Read more

At a CAGR of 10.1% Lateral Fitness Equipment to Reach $10.7 Billion by 2027

(MENAFN – EIN Presswire) https://img.einpresswire.com/large/167817/lateral-fitness-equipment-marke.jpeg#790×466

Lateral Fitness Equipment Market

Market to witness significant growth due to introduction of high-tech technology such as television screen, CSAFE connectivity, iPod compatibility, sound system

Surge in number of gym memberships, rise in sale of in-home equipment, upsurge in urban population & increase in government initiatives to promote healthy life is further boost the overall revenue. — SwatiPORTLAND, OR, UNITED STATES, December 1, 2020 /[To enable links contact MENAFN] EINPresswire.com/ — According to a new report published by Allied Market Research, titled, ‘[To enable links contact MENAFN] Lateral Fitness Equipment Market by Type, Body Type, End User, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2020–2027,’ the global lateral fitness equipment market size was valued at $5.4 billion in 2020, and is projected to reach $10.7 billion by 2027, registering a CAGR of 10.1% from 2020 to 2027. Lateral fitness equipment is any machine or device required for physical exercise to manage overall weight, improve physical stamina, and develop muscular strength. Lateral fitness equipment market demand has increased globally, due to increase in health awareness. In addition, physical exercise is advised during certain medical treatments. The most commonly used lateral fitness equipment include treadmills, elliptical, stationary bicycles weightlifting machines & strength building machines, and others.Increase in health awareness and rise in need for active, healthy lifestyle across the world majorly boost the growth of the lateral fitness equipment market. Sedentary lifestyle and changes in eating habits have led to increase in health risks. Therefore, increase in awareness toward regular physical activities to maintain healthy lifestyle fuels the growth of the lateral fitness equipment market.

Moreover, availability of smart gym equipment has made the lateral fitness exercises interesting and entertaining. Smart gym equipment is a type of equipment that is connected to an app that records workouts and also displays the data about workout. These connected gym equipment are linked to the internet and record all data such as workout goals, nutritional habits, and health history through cloud based data. This data helps in creating a personalized exercise plan and also track the workout. Furthermore, implementation of technologies like IoT and AI in lateral fitness equipment help connect the machines with smartphone, which also augment the growth of lateral fitness equipment market. In addition, treadmills, elliptical, and stationary bikes are the most popular high-tech lateral fitness machines owing to the presence of television screens, Bluetooth connectivity, iPod compatibility, sound system, CSAFE connectivity and other features. Thus, increase in implementation of high-tech features is anticipated to provide lucrative lateral fitness equipment market opportunity and eventually increase its customer base.

Download PDF Sample Report @ [To enable links contact MENAFN]

The number of social media users has increased considerably with rise in internet penetration. Taking this into consideration, most of the key players in the lateral fitness equipment market strategize on promoting their products and services on these social media platforms. Social media marketing is one of the major strategies adopted by various companies and

Read more

Global fitness app market size valuation to reach USD 15.96 billion by 2026

Selbyville, Delaware, Nov. 24, 2020 (GLOBE NEWSWIRE) — As per reliable estimates, worldwide fitness app market size is predicted to reach USD 15.96 billion mark by 2026. Rising concerns associated with unhealthy habits, evolving consumer lifestyle, and growing obese population are some of the key factors propelling the market expansion.

The study elaborates on several market segmentations including app type, device type, OS platform type, and regional outlook. Additionally, the document conducts a thorough SWOT analysis of various companies operating in this business sphere.

The research report also analyzes the impact of COVID-19 outbreak on industry expansion graph and valuation in the ensuing years, further allowing for advanced decision-making during investment assessment.

Request Sample copy of this Report @https://www.marketstudyreport.com/request-a-sample/1695317/

The surge in obese population coupled with rising adoption of sedentary lifestyle have resulted in increased pervasiveness of diseases such as hypertension and diabetes. In addition to this, rising per capita income along with increasing awareness pertaining to health and nutrition are stimulating the overall industry outlook.

According to industry analysts, the number of gym and health club memberships has significantly increased in the recent past. Additionally, rising smartphone penetration, widespread adoption of mobile devices, and easy accessibility to high-speed internet are positively impacting the remuneration scale of global fitness app market.

Availability of numerous types of fitness apps such as Sweat: Kayla Itsines Fitness and Runstatic coupled with high concentration of companies are also facilitating the business scenario. In 2015 for instance, Adidas acquired the Austrian company Runstatic in order to improve its overall market share. Thus, focus among major companies towards expanding their product portfolio through innovative launches and strategic collaborations are aiding the expansion of global fitness app market.

Highlighting the regional outlook

Global fitness app industry is bifurcated into North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. According to authentic estimations, North America is expected to capture majority market share by the year 2026.

Growing population and surging disposable income are favoring the regional market outlook. Moreover, widespread adoption of sedentary lifestyle and rising health concerns have augmented the demand for fitness apps, which in turn is positively swaying the business dynamics in North America.

Meanwhile, Asia-Pacific fitness app market is set to record the highest CAGR through 2026. Factors such as growing purchasing power, rising health cognizance, high concentration of fitness centers, and increasing smartphone penetration have allowed Asia-Pacific to emerge as a major revenue generator for worldwide fitness app market.

To access a sample copy or view this report in detail along with the table of contents, please click the link below:

https://www.marketstudyreport.com/reports/fitness-app-market-share-size-trends-industry-analysis-report-by-app-type-fitness-and-activity-tracking-diet-and-nutrition-by-device-type-smartphones-tablets-wearable-devices-by-gender-by-os-platform-by-region-segment-forecast-2018-2026

Global Fitness App Market by App Type (Revenue, USD Billion, 2015-2026)

  • Medication Adherence
  • Lifestyle Management
  • Nutrition & Diet
  • Disease Management
  • Workout & Exercise Apps

Global Fitness App Market by Device Terrain (Revenue, USD Billion, 2015-2026)

  • Wearable Devices
  • Tablets
  • Smartphones

Global Fitness App Market by OS Platform (Revenue, USD Billion, 2015-2026)

Global Fitness App Market Regional Outlook (Revenue, USD Billion, 2015-2026)

North America

Europe

  • Netherlands
  • Russia
  • Belgium
  • Spain
Read more

Global Herceptin Biosimilar Market to Surpass US$ 5.8 Billion by 2027, Says Coherent Market Insights (CMI)

According to Coherent Market Insights, the global herceptin biosimilar market is estimated to be valued at US$ 1.3 billion in 2020 and is expected to exhibit a CAGR of 24.5 % over the forecast period (2020-2027).

Key Trends and Analysis of the Global Herceptin Biosimilar Market:

Key players are focused on obtaining product approvals to strengthen their position in the global herceptin biosimilar market. For instance, in June 2020, Roche Holding AG received the US Food Drug and Administration approval for Phesgo, a fixed-dose combination of Perjeta (pertuzumab) and Herceptin (trastuzumab) with hyaluronidase, a subcutaneous injection with combination with intravenous chemotherapy for treatment of early and metastatic breast cancer.

Moreover, key players are focused on launching products to strengthen their product portfolio in the global herceptin biosimilar market. For instance, in 2019, Samsungbioepis Co,.Ltd, received approval for its first oncology treatment, Ontruzant, a biosimilar of herceptin and received the approval from US Food Drug and Administration. The product is approved for treatment of metastatic HER2-overexpressing BC, early HER2-overexpressing BC, and advanced gastric cancer in the U.S.

Among regions, North America is expected to register highest growth rate due to the increasing prevalence of diseases such as colorectal cancer, breast cancer and lung cancer in women. The US National Library of Medicine’s report published in September 2020 stated that around breast, lung and colorectal cancer accounted for 50% of the overall cancer incidence in women in the US.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4258

Key Market Takeaways:

The global herceptin biosimilar market is expected to exhibit a CAGR of 24.5 % over the forecast period owing to the increasing prevalence of diseases such as gastric cancer and breast cancer in females and product approvals and launches in the global herceptin biosimilar market.

Competitive Landscape:

Key players operating in the global herceptin biosimilar market are Amgen Inc., AryoGen Biopharma, Biocon Limited, Celltrion Inc., Pfizer Inc., Merck & Co., Inc., Accord Healthcare Ltd, Gedeon Richter Plc, Genor Biopharma Company Ltd, Mabion SA, Mylan N.V, Roche Holding AG and Samsungbioepis Co,.Ltd.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4258

Market Segmentation:

  • Global Herceptin Biosimilar Market, By Indication:

    • Breast Cancer

    • Gastric Cancer

    • Others

  • Global Herceptin Biosimilar Market, By Distribution Channel :

    • Hospitals

    • Oncology Centers

    • Others

  • Global Herceptin Biosimilar Market, By Region:

    • North America

    • Latin America

      • By Country:

        • Brazil

        • Mexico

        • Argentina

        • Rest of Latin America

    • Europe

      • By Country:

        • Germany

        • U.K.

        • France

        • Italy

        • Spain

        • Russia

        • Rest of Europe

    • Asia Pacific

      • By Country:

        • China

        • India

        • Japan

        • Australia

        • South Korea

        • ASEAN

        • Rest of Asia Pacific

    • Middle East

      • By Country/Region:

        • GCC

        • Israel

        • Rest of Middle East

    • Africa

      • By Country/Region:

        • South Africa

        • Central Africa

        • North Africa

Related Market Intelligence Report:

Biosimilars Market, by Drug Class (Recombinant Human Growth Hormone, Granulocyte Colony-Stimulating Factor, Insulin, Anticoagulants, Fusion Proteins, Erythropoietin, Monoclonal Antibodies, Follitropin, and Others), by Therapy Type (Oncology, Immunology, Hematology, Hormone Therapy, Metabolic Disorders, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Specialty Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) –

Read more

Online Fitness Market Size to Reach USD 59,231 Billion by 2027 | CAGR of 33.1%

BANGALORE, India, Oct. 29, 2020 /PRNewswire/ — Online/Virtual Fitness Market by Streaming Type (Live, and On-demand), Device Type (Smart TV, Smartphones, Laptops Desktops & Tablets, and Others), Session Type (Group and Solo), Revenue Model (Subscription, Advertisement, and Hybrid) and End User (Professional Gyms, Sports Institutes, Defense Institutes, Educational Institutions, Corporate Institutions, Individuals, and Others): Global Opportunity Analysis and Industry Forecast, 2020-2027 – Published on Valuates Reports in Beauty & Fitness Category.

Valuates Reports Logo

The global Online fitness market size was valued at USD 6,046 Million in 2019 and is projected to reach USD 59,231 Million by 2027, growing at a CAGR of 33.1% from 2020 to 2027.

North America is expected to hold the largest Online Fitness Market share during the forecast period. The major factor driving the growth of North America’s market share is the increased emphasis on precision medicine and personalized treatment and the significant presence of numerous health and wellness organizations across this region.

Major factors driving the growth of online fitness market size are the need for specialized fitness sessions to achieve physical fitness, the interest of health insurance companies in online fitness services to minimize the cost of health insurance, increasing demand for fitness based on AR or VR, growing demand for healthy food.

Furthermore, recent COVID-19 has had a positive effect on the online fitness market size. The COVID-19 pandemic has disrupted people’s lives and forced fitness centers to remain closed. This scenario has, in turn, led to the rapid adoption of virtual fitness solutions as individuals have begun workouts at their homes.

Request a Sample Copy of the Report For COVID-19 Impact Analysis on Online Fitness Market: https://reports.valuates.com/request/sample/ALLI-Manu-0V29/online_fitness_industry

TRENDS INFLUENCING THE ONLINE FITNESS MARKET SIZE

The increase in digitalization will propel the expansion of the online fitness market size along with the trend of connected fitness equipment that allows users to monitor health parameters, such as pulse rate and calories. Several businesses are launching virtual classes that allow users to incorporate fitness experiences with their smart devices.

The rising penetration of smart devices and the internet is expected to increase the growth of the online fitness market size. The penetration of smartphones and tablets has resulted in high fitness app adoption across all demographics. Some apps provide personalized services based on specifications and body physiology.

Corporate institutions that incorporate gyms into their infrastructure would boost the demand for the online fitness industry. Several fitness clubs partner with businesses to facilitate the introduction of gyms to improve employee productivity in the work environment.

Awareness about the growing health issues due to sedentary lifestyles is fueling the online fitness market size. Increasing rates of obesity and associated disorders, including heart attacks and diabetes, enable individuals to take individual fitness lessons to cope with specific health problems.

However, interruptions in the class flow due to tech glitches, along with the lack of real contact with the teacher, may, to some degree, impede the growth of the online fitness industry.

View market snapshot before purchasing

ONLINE FITNESS

Read more

EPA/DHA (Omega3) Ingredients Market to reach $3.8 billion by 2026, Says Global Market Insights, Inc.

EPA/DHA (Omega3) Ingredients Industry projected to register more than 7% CAGR between 2020 and 2026, impelled by increasing consumer awareness for omega-3 fortified products.

Selbyville, Delaware, Oct. 29, 2020 (GLOBE NEWSWIRE) —

The EPA/DHA (omega3) ingredients market value is expected to cross USD 3.8 Billion by 2026, according to a new research report by Global Market Insights, Inc. Growing awareness about the functional benefits of EPA/DHA ingredients and increasing and increasing health care cost is anticipated to propel the industry outlook.

EPA/DHA (Omega3) Ingredients industry from EPA is expected to register over 8.6% CAGR through 2026, due to the virtue of increasing high quality supplements and increasing product penetration. Since, EPA fatty acid supplements help to support good heart health along with weight management, child development, and joint health. EPA metabolizes to produce hormone like substances called eicosanoids which are responsible regulating cell growth, muscle activity, hormone secretion and blood clotting. Thereby, demand for EPA/DHA(Omega3) ingredients is anticipated to grow. Moreover, rising incidences of various diseases like cardiovascular disease, diabetes and hormonal issues owing to hectic lifestyle and harmful dietary habits will boost product demand.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/118

The global economy is hit by COVID- 19 pandemic where, even after continuing the operations, many nations are facing challenges of resuming their production capacity and manufacturers are experiencing the effect of shortages in their distribution networks. However, increasing electricity demand and robust growth across the healthcare sector is anticipated to amplify the product installation.

Some major findings of the EPA/DHA (omega3) ingredients market report include:

  • The gradual shift of consumers towards dietary and functional food has gain traction owing to its high protein and nutrition content will foster the global Market trends.

  • Increasing incorporation of EPA/DHA ingredients in infant formulas is one of the defining trends which creates favourable market demand.

  • EPA/DHA (omega3) ingredients demand from animal & pet feed is expected to register over 9.8% CAGR through owing to increasing number of pet ownership.

  • High demand of clean label products is creating lucrative growth opportunities for the market.

  • EPA/DHA ingredients sourced from plant such as algae is likely to gain traction in the market due to increasing vegan population.

  • Key players operating in the market are continuously investing in research and development activities in order to monitor its product offerings and exhilarate ever rising demand of consumers.

  • Increasing application scope in cancer treatment may drive the industry demand. Rise in R&D expenditure to develop omega 3 clinical nutrition products and pharmaceutical drugs should have positive influence on product demand.

  • Some of the major players operating in the market are BASF, Koninklijke DSM N.V., Croda International plc, Omega Protein, Nordic Naturals, Inc., Copeinca ASA, Epax Norway AS, Arista Industries, Inc., GC Rieber, Solutex, Olvea and Lysi others.

Browse key industry insights spread across 300 pages with 396 market data tables and 30 figures & charts from the report, “EPA/DHA (Omega3) Ingredients Market Forecasts By Application (Dietary supplements, Pharmaceuticals, Functional Foods, Pet & Animal

Read more

Global Herbal medicine market size to exceed USD 411 billion by 2026

The latest report on ‘herbal medicine market’ thoroughly scrutinizes this business space while providing qualitative insights, historical data, and verifiable projections for 2020-2026 to the companies that are operational in this industry.

Selbyville, Delaware, Oct. 29, 2020 (GLOBE NEWSWIRE) — According to the credible sources, global herbal medicine market is expected to reach a valuation of USD 411.2 billion by the year 2026. Increasing product adoption by the population across the world, rising support & funding from government for research & development of herbal medicines, and easy availability of the product are the major factors propelling the industry growth. Further, benefits such as low cost, and no side effects are also contributing to herbal medicine market outlook.

Global herbal medicine market report studies the landscape based on several segmentations, such as source type, distribution channel, category, form, and regional outlook. It enlists the factors that influence the segmental share along with their growth rate projections over the analysis timeframe. Furthermore, the document contains granular information about competitive landscape of the market defined by each participant, along with their business profile, product portfolio, and market stake.

Highlighting category

Estimates cites that herbal pharmaceuticals segment held a major share in global herbal medicine industry in 2019, owing to rising geriatric population, and high consumer awareness. Other factors like negligible side effects, supplier innovations, and launch of Current Good Manufacturing Practices (CGMP) by the FDA for dietary supplements are expected to drive the segmental growth.

Meanwhile, herbal beauty products segment is predicted to register robust growth rate during the forecast period, mainly due to increase in sales of beauty products. High disposable income, and availability of large product portfolio are stimulating the overall market remuneration.

Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/2963796/

Elaborating form outlook

Global herbal medicine market, as per form type, is segmented into powders, tablets & capsules, syrups, extracts, and others. Among these, extract segment is expected to witness high gains during the forecast period, owing to its utilization in manufacturing several products. Herbs & plants extracts vary from alcoholic extracts, hot water extracts to long-term boiled extracts, and acetic acid extracts depending on the solvent.

Considering source type

As per the report, whole plant sourced herbal medicine market segment is gaining substantial traction due to product’s ability to cure various diseases. As per National Center for Biotechnology Information, about 70% to 80% of the population worldwide preferred traditional drugs for treatment.

Notably, traditional medications are extracted from roots & barks, leaves, fruits, flowers, stalk, and cloves of the plant. For instance, chamomile, a flower, is used as sedative and anxiolytic for relaxation and anxiety. It also reduces swelling and inflammation while aiding in wound healing.  

Analyzing distribution channel

Worldwide herbal medicine market share from e-commerce segment is projected to grow momentously during the forecast period, owing to rising awareness regarding traditional medication, high penetration of mobile phones with internet facilities, and easy accessibility in small towns & villages. Further, rising geriatric population, and cost efficiency of

Read more

Whoop, maker of the fitness tracker that pro athletes love, is now valued at $1.2 billion

  • Whoop has closed a $100 million Series E Financing round, valuing the company at $1.2 billion.
  • Several professional athletes including Patrick Mahomes and Rory McIlroy are investors in the company
  • Whoop has seen a surge in business during the coronavirus pandemic as it has been an effective tool for some of its users in noticing early onset Covid symptoms.



Patrick Mahomes holding a frisbee: Patrick Mahomes is an investor in Whoop's latest round of funding.


© Provided by CNBC
Patrick Mahomes is an investor in Whoop’s latest round of funding.

Some of the biggest names in sports are investing in the wearable company Whoop amid a global pandemic.

The fitness tracking company announced Wednesday it closed a $100 million financing round, valuing it at $1.2 billion. 

The latest round of investors includes Super Bowl MVP Patrick Mahomes, champion golfers Rory McIlroy and

PGA Tour golfer Justin Thomas on playing amid coronavirus

UP NEXT

UP NEXT

Arizona Cardinals wide receiver Larry Fitzgerald and two-time NBA Finals MVP Kevin Durant (via his business venture ThirtyFive Ventures).

Whoop makes fitness trackers that can monitor vitals like movement, sleep and workouts. It’s been the fitness tracker of choice for a number of recognizable pro athletes, and has been used to help monitor potential symptoms of Covid-19 as sports came back after play was suspended due to the pandemic in the spring.

Loading...

Load Error

“I’ve always loved Whoop the product, but I learned that Whoop the business was just as good. I’m proud to be investing again in this round of financing and very excited about the company’s prospects,” McIlroy said in a statement. The four-time Majors Champion also serves as a global ambassador to Whoop.

The funding round was led by venture capital firm IVP, which will get a board seat with Whoop. Other participating investors include SoftBank Vision Fund 2, Accomplice, Two Sigma Ventures, Collaborative Fund, Thursday Ventures, Nextview Ventures, Promus Ventures, Cavu Ventures and D20 Capital.

“A lot of the capital will go towards investing in membership, the overall experience, software, analytics and hardware,” Will Ahmed, Whoop CEO said in an interview with CNBC. “It’s really about bolstering the coaching aspect of Whoop. We aspire to be a 24/7 life coach to tell you what you need to do to improve.”

The Boston-based sports wearable company got its start in 2012 and now has more than 330 employees after a surge of recent hires. Ahmed said the company has hired 200 new employees in 2020.

The company wouldn’t provide revenue numbers but said its subscribers have been growing quickly over the last 12 months due to an increased interest in health during the pandemic. Whoop has raised more than $200 million in funding to date.

“Whoop has built best-in-class wearable technology and an aspirational brand that have propelled the company to an impressive period of hypergrowth,” Eric Liaw, General Partner at IVP, said in a statement.

Ahmed said Whoop members range from professional athletes, Fortune 500 CEOs and fitness enthusiasts. The nylon band equipped with sensors is designed to gather data to measure everything from exertion levels

Read more

Whoop raises $100 million, valuing the fitness tracker startup at $1.2 billion

(Reuters) – Fitness tracker startup Whoop said on Wednesday it raised $100 million in Series E funding from investors including venture capital firm IVP and SoftBank Vision Fund 2, valuing the company at $1.2 billion.

Popular athletes like 10-time NBA All-Star Kevin Durant, Super Bowl MVPs Patrick Mahomes and Eli Manning, among others, also participated in the funding round, the company said in a statement here.

Boston-based Whoop said it would primarily use the new funds for product and software development, global expansion and membership services.

Whoop also offers a monthly subscription for round-the-clock health monitoring through a free fitness band it provides with the membership.

The company’s tracker is the fitness band of choice for a host of pro-athletes. The PGA Tour had bought 1,000 Whoop bands for players, caddies and media covering the golf tournament.

Whoop founder Will Ahmed said customers were increasingly using the technology to measure their respiratory rate, which is a key statistic for understanding COVID-19.

Founded in 2012, the company said it has raised over $200 million till date.

Reporting by Ayanti Bera in Bengaluru; Editing by Devika Syamnath

Source Article

Read more

Antibiotics Market to Reach $50.37 Billion by 2025 at 2.1% CAGR, Says Allied Market Research

Rise in consumption of antibiotics in low & middle-income countries (LMICs), heavy inflow of investments for R&D activities by biotech companies, and supportive rules & regulations would propel the growth of the global antibiotics market

Portland, OR, Oct. 28, 2020 (GLOBE NEWSWIRE) — The report provides detailed analyses of the top winning strategies, driving forces & opportunities, key market segments, competitive landscape, and strategic developments. As per the report, the global Antibiotics Market  generated $42.33 billion in 2017 and is expected to reach $50.37 billion by 2025, registering a CAGR of 2.1% from 2018 to 2025.

Increasing utilization of antibiotics in low and middle-income countries (LMICs) due to high incidence of severe infections, high capital allocation for R&D activities by biotech companies, and supportive norms and regulations drive the growth of the market. However, development of antibiotic resistance and rise in drug approval costs hinder the market growth. Conversely, discovery of advanced prospect molecules and innovative combination therapies for the treatment of antibiotic-resistant microbial infections would create opportunities for the market in future.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/5072

Beta lactam and beta lactamase inhibitors segment to maintain its dominance by 2025 

The beta lactam and beta lactamase inhibitors segment contributed nearly two-thirds of the total market share in 2017 and is expected to maintain its dominance by 2025. This is due to rise in demand for its effectiveness in treating Gram-positive & Gram-negative bacteria as well as use in the treatment of broad-spectrum of infections. However, quinolones segment would register the fastest CAGR of 4.3% from 2018 to 2025, owing to their characteristics such as remarkable oral bioavailability, good tissue penetration, and high broad-spectrum bactericidal activity, especially in new generation quinolones. The report also analyzes macrolides and others.

Semisynthetic segment to lead throughout the forecast period 

The semisynthetic segment accounted for more than one-third of the total market share in 2017 and will continue to maintain its lead by 2025. This is due to the enhanced coverage and efficacy against a wide range of organisms as well as ease in administration and cost effectiveness as compared to other antibiotics. However, the synthetic segment would register the fastest CAGR of 2.7% from 2018 to 2025 due to high demand for synthetic membrane-targeted antibiotics, broad spectrum activity, rapid bactericidal activity, no cross-resistance with existing antibiotics, and low probability of developing resistance. The report also discusses antibiotics of natural origin.

Broad-spectrum antibiotics segment to be lucrative by 2025 

Broad-spectrum antibiotics segment contributed more than two-thirds of the total market share in 2017. This segment would dominate by 2025, registering the fastest CAGR of 2.4% from 2018 to 2025. This is attributed to the growing demand for broad-spectrum antibiotics to curb widespread antimicrobial resistance. The research also discusses narrow-spectrum antibiotics.

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/5072

Intravenous segment to dominate in terms of revenue during the forecast period  

Intravenous route of administration segment accounted for nearly half of the total market share in 2017, owing to the rise in incidence of severe infections, which

Read more